»ó´Ü¿©¹é
±â»ç (Àüü 407°Ç)
[RTM] ÃÖÀûÀÇ ÀÌ»óÁöÁúÇ÷Áõ °ü¸®¸¦ À§ÇÑ
½ºÅ¸Æ¾/ºñ½ºÅ¸Æ¾ Àü·«ÀÇ ÀÓ»óÀû ¿ªÇÒ
› OPENING REMARKÁÂÀå ³ª½Â¿î ¿À´Ã ¿ù°£ ´õ¸ð½ºÆ®°¡ ÁøÇàÇÏ´Â Á´ãȸ(Round Table Meeting)ÀÇ ÁÂÀå...
THE MOST  |  2024-03-27 17:46
¶óÀÎ
[RTM] ÇÇŸ¹Ù½ºÅ¸Æ¾, ÇÇŸ¹Ù½ºÅ¸Æ¾/¿¡Á¦Æ¼¹Ìºê
ÇÇŸ¹Ù½ºÅ¸Æ¾, ÇÇŸ¹Ù½ºÅ¸Æ¾/¿¡Á¦Æ¼¹Ìºê Clinical KeypointsLDL-C °­ÇÏÈ¿°úÇÇŸ¹Ù½ºÅ¸Æ¾ÀÇ LDL-ÄÝ·¹½ºÅ×·Ñ(LDL-C) °­...
THE MOST  |  2024-03-27 16:34
¶óÀÎ
[Sub Story] Çѱ¹ÀÎ ¹ÝÀÀ·ü °í·ÁÇϸé Áß°­µµ ÃæºÐÈ÷ È¿°úÀû
µ¿¹ÝÁúȯÀÌ»óÁöÁúÇ÷ÁõÀº ´ç´¢º´ ȯÀÚÀÇ ´ëÇ÷°üÇÕº´Áõ ¿¹¹æÀ» À§ÇØ ¹Ýµå½Ã Àâ¾Æ¾ß ÇÏ´Â ½ÉÇ÷°üÁúȯ À§ÇèÀÎÀÚ Áß Çϳª·Î Áö¸ñµÇ°í ÀÖ´Ù. ±× ¸¸Å­...
ÀÌ»óµ· ±âÀÚ  |  2024-03-15 16:24
¶óÀÎ
[Interview] ¡°°í°­µµ ½ºÅ¸Æ¾ Á¦Á¦ È¿°ú ´ëµîÇϳª ¾ÈÀü¼º ´Ù¸¦ ¼öµµ¡±
Q. CAD ȯÀÚÀÇ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀü·«Àº?Çѱ¹ÁöÁú¡¤µ¿¸Æ°æÈ­ÇÐȸ Áø·áÁöħ¿¡¼­ °ü»óµ¿¸ÆÁúȯ(CAD) º´·ÂÀÚÀÇ LDLÄÝ·¹½ºÅ×·Ñ(LDL-C)...
ÀÌ»óµ· ±âÀÚ  |  2024-03-14 17:41
¶óÀÎ
[Sub Story] Ç×°íÇ÷¾ÐÁ¦+½ºÅ¸Æ¾ º´¿ëÄ¡·á´Â ±Ù°ÅÁß½ÉÀÇÇÐ ´ëÇ¥»ç·Ê
´ë»çÁõÈıº°íÇ÷¾ÐÀÌ ÀÌ»óÁöÁúÇ÷Áõ ¿Ü¿¡µµ °íÇ÷´ç¡¤º¹ºÎºñ¸¸ µî ¿©Å¸ ½ÉÇ÷°üÁúȯ À§ÇèÀÎÀÚ¿Í µ¿¹ÝµÅ »óÈ£ÀÛ¿ëÇÏ¸ç ½ÉÇ÷°üÁúȯ À§ÇèÀ» ´õ Áõ°¡½ÃŲ´Ù...
ÀÌ»óµ· ±âÀÚ  |  2024-03-13 14:48
¶óÀÎ
[Late Breaking Studies] ÇÇŸ¹Ù½ºÅ¸Æ¾, Á׻󵿸ưæÈ­Áõ ÅðÇà °¡´É¼º ½Ã»ç
REPRIEVE ÇÏÀ§ºÐ¼®À̹ø ÇÏÀ§ºÐ¼®Àº 2015~2018³â ¹Ì±¹ 31°³ ¿¬±¸±â°ü¿¡¼­ ÁøÇàµÈ ¹«ÀÛÀ§¡¤´ëÁ¶±º ÀÓ»ó½ÃÇèÀÎ REPRIEVE ¸ð...
Á¤¿¬ÁÖ ±âÀÚ  |  2024-03-13 14:32
¶óÀÎ
[Sub Story] ½ºÅ¸Æ¾, ½ÉÇ÷°üÁúȯ 2Â÷¿¹¹æ¿¡ ±â¿©
100mg/dL → 70mg/dLÁö±ÝÀÌ¾ß 55mg/dL ¹Ì¸¸±îÁö ³»·Á¿ÔÁö¸¸, ½ÉÇ÷°üÁúȯ º´·ÂÀÚ µî ÃÊ°íÀ§Ç豺ÀÇ 2Â÷¿¹¹æÀ» À§ÇØ...
ÀÌ»óµ· ±âÀÚ  |  2024-03-12 14:52
¶óÀÎ
[Interview] ¡°°íÇ÷¾Ð¡¤ÀÌ»óÁöÁúÇ÷Áõ µ¿¹ÝÄ¡·á SPC Àü·«À¸·Î À¯È¿¼º¡¤¼øÀÀµµ Á¦°í¡±
Q. °íÇ÷¾Ð°ú ÀÌ»óÁöÁúÇ÷ÁõÀÇ µ¿¹ÝÀÌȯÀ²Àº?´ëÇÑ°íÇ÷¾ÐÇÐȸÀÇ Korea Hypertension Fact Sheet 2023¿¡ µû¸£¸é, 20...
ÀÌ»óµ· ±âÀÚ  |  2024-03-12 14:41
¶óÀÎ
[Cover Story] Çѱ¹ÀÎ ¸¸¼ºÁúȯÀº ¿ë±¤·Î¡¤ºñºö¹äÀÌÀÚ º¹ÇÕÇü
K-¸¸¼ºÁúȯÁö±Ý±îÁö ¾ð±ÞÇÑ ³»¿ëÀº ¸¸¼ºÁúȯÀÇ ÀϹÝÀûÀÎ º´Å»ý¸®¸¦ ¾ð±ÞÇÑ °ÍÀÌ´Ù. ÇÏÁö¸¸ ¸¸¼ºÁúȯÀº Áö¿ª¡¤ÀÎÁ¾º°·Î Â÷À̸¦ ³ªÅ¸³»±âµµ ÇÑ´Ù...
ÀÌ»óµ· ±âÀÚ  |  2024-03-12 09:08
¶óÀÎ
[Journal Briefing] ¿¬ 2ȸ ÁÖ»ç·Î LDL-C ¸ñǥġ¿¡ Çѹߦ ´õ
Çѱ¹Àο¡¼­µµ ¿¬ 2ȸ ÁÖ»ç·Î LDLÄÝ·¹½ºÅ×·Ñ(LDL-C) Á¶ÀýÈ¿°ú¸¦ º¼ ¼ö ÀÖÀ» °ÍÀ¸·Î Àü¸ÁµÈ´Ù. À̹ø ORION-18 ¿¬±¸¿¡¼­´Â Á×»ó...
Á¤¿¬ÁÖ ±âÀÚ  |  2024-03-08 09:44
¶óÀÎ
[Journal Briefing] 3Á¦º¹ÇÕÁ¦, Ç÷¾Ð¡¤ÁöÁú °³¼±È¿°ú ´Üµ¶º¸´Ù ¿ì¼ö
ÀÌ»óÁöÁúÇ÷Áõ°ú °íÇ÷¾ÐÀ» µ¿¹ÝÇÑ È¯ÀÚ¿¡¼­ 3Á¦ º¹ÇÕÁ¦°¡ 2Á¦ ¶Ç´Â ´ÜÀÏÁ¦º¸´Ù Ç÷¾Ð°­ÇÏ ¹× ÁöÁú°³¼± È¿°ú°¡ ¿ì¼öÇÑ °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ÀÌÀü ...
Á¤¿¬ÁÖ ±âÀÚ  |  2024-02-20 11:01
¶óÀÎ
[Sub Story] ´ç´¢º´ ȯÀÚ Ç×°íÇ÷¾ÐÁ¦ º´¿ë 150/90mmHg ÀÌ»óºÎÅÍ
Ç÷´ç°­ÇÏÁ¦¿Í ½ÉÇ÷°ü ÇýÅÃADA´Â Á׻󵿸ưæÈ­¼º ½ÉÇ÷°üÁúȯ(ASCVD) º´·Â ¶Ç´Â °íÀ§Ç豺ÀÇ 2Çü´ç´¢º´ ȯÀÚ¸¦ Ä¡·áÇÏ´Â °æ¿ì¿¡ ƯÁ¤ °è¿­...
ÀÌ»óµ· ±âÀÚ  |  2024-02-07 15:43
¶óÀÎ
[Journal Briefing] ÇÇŸ¹Ù½ºÅ¸Æ¾ ½ÉÇ÷°üÁúȯ 1¡¤2Â÷¿¹¹æ¿¡ ¸ðµÎ ÇÕ°ÝÁ¡
ÇÇŸ¹Ù½ºÅ¸Æ¾±¹³»¿Ü °¡À̵å¶óÀο¡¼­ ÀÌ»óÁöÁúÇ÷Áõ Ä¡·á¸¦ À§ÇÑ LDL-C ¸ñǥġ°¡ Á¡Á¡ °­È­µÇ¸é¼­ ´õ °­·ÂÇÑ Ä¡·áÀü·«ÀÌ Àý½ÇÇØÁ³´Ù. ÇÑÆí ½ÉÇ÷°üÁúȯ ÃÊ°íÀ§Ç豺 ȯÀÚ¿¡¼­ 1Â÷Ä¡·á·Î °í°­µµ ½ºÅ¸Æ¾¿ä¹ýÀÌ ±Ç°íµÇ°í Àִµ¥, °í¿ë...
Á¤¿¬ÁÖ ±âÀÚ  |  2024-02-07 15:24
¶óÀÎ
[Interview] ¡°Áß¼ºÁö¹æ Á¶Àý¾àÁ¦·Î Æä³ëÇǺ극ÀÌÆ® ¿ì¼± °í·ÁÇؾߡ±
Q. ³ôÀº Áß¼ºÁö¹æ°ú ½ÉÇ÷°üÁúȯ À§ÇèÁõ°¡ÀÇ »ó°ü°ü°è´Â ¾î¶»°Ô ±Ô¸íµÆ³ª?À¯ÀüÀÚ°¡ Áúº´¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» È®ÀÎÇØ ¿¬°ü¼ºÀ» ÆľÇÇÒ ¼ö ÀÖ´Â ¸à...
ÀÌ»óµ· ±âÀÚ  |  2024-02-07 15:21
¶óÀÎ
[Sub Story] ÀÜ¿© ½ÉÇ÷°ü À§Çè ±Øº¹¿¡ Æä³ëÇǺ극ÀÌÆ® ¿ì¼¼
ÀÜ¿© ½ÉÇ÷°ü À§ÇèÀÌ»óÁöÁúÇ÷Áõ Ä¡·áÀÇ 1Â÷¸ñÇ¥´Â LDLÄÝ·¹½ºÅ×·Ñ(LDL-C) Á¶ÀýÀÌ´Ù. 1Â÷Ä¡·á ¼±ÅÃÀÎ ½ºÅ¸Æ¾À» ÅëÇØ LDL-C¸¦ ¸ñǥġ ¹Ì¸¸À¸·Î ÁÙÀÌ°í, ´õ ³ª¾Æ°¡ ½ÉÇ÷°üÁúȯÀÇ Ã¹¹ß»ý ¶Ç´Â Àç¹ßÀ» ¿¹¹æÇÏÀÚ´Â °ÍÀÌ´Ù....
ÀÌ»óµ· ±âÀÚ  |  2024-02-07 15:15
¶óÀÎ
[Sub Story] º¹ÇÕÇü ÀÌ»óÁöÁúÇ÷ÁõÀº Á׻󵿸ưæÈ­Áõ È£¹ß¼º
º¹ÇÕÇü ÀÌ»óÁöÁúÇ÷Áõº¹ÇÕÇü ÀÌ»óÁöÁúÇ÷Áõ ³ôÀº LDLÄÝ·¹½ºÅ×·Ñ, ³ôÀº Áß¼ºÁö¹æ, ³·Àº HDLÄÝ·¹½ºÅ׷ѱîÁö ÀÌ»óÁöÁúÇ÷ÁõÀ» ±¸¼ºÇÏ´Â ´ëÇ¥ÀûÀÎ ...
ÀÌ»óµ· ±âÀÚ  |  2024-02-07 15:12
¶óÀÎ
[Interview] ½ÉÇ÷°üÁúȯ 2Â÷¿¹¹æ¿¡ ȯÀÚº° ½ºÅ¸Æ¾ ¸ÂÃãÄ¡·á ±Ù°Å ¸¶·ÃµÅ
Q. LODESTAR ¿¬±¸¸¦ ÁøÇàÇÏ°Ô µÈ ¹è°æÀº?°ú°Å ÀÌ»óÁöÁúÇ÷Áõ °¡À̵å¶óÀο¡¼­´Â °ü»óµ¿¸ÆÁúȯ º´·ÂÀÚ¿Í °°Àº °í¡¤ÃÊ°íÀ§Ç豺 ÀÌ»óÁöÁúÇ÷Áõ...
ÀÌ»óµ· ±âÀÚ  |  2024-02-07 11:48
¶óÀÎ
[Sub Story] ´ç´¢º´ ȯÀÚ LDL-C Á¶Àý¿¡µµ ½ºÅ¸Æ¾
The Lower, The BetterÇѱ¹ÁöÁú¡¤µ¿¸Æ°æÈ­ÇÐȸ´Â Áö³­ 2022³â ¡®ÀÌ»óÁöÁúÇ÷Áõ Áø·áÁöħ Á¦5ÆÇ¡¯À» ¹ßÇ¥, LDLÄÝ·¹½ºÅ×·Ñ ...
ÀÌ»óµ· ±âÀÚ  |  2024-02-07 11:42
¶óÀÎ
[Journal Briefing] ½ºÅ¸Æ¾ º´¿ë¿ä¹ý, °í°­µµ ´Üµ¶ ´ëºñ ºñ¿­µîÇØ
µ¿¸Æ°æÈ­¼º ½ÉÇ÷°üÁúȯ(ASCVD) ȯÀÚ¿¡¼­ Áß°­µµ ½ºÅ¸Æ¾ + ¿¡Á¦Æ¼¹Ìºê º´¿ë¿ä¹ýÀÌ °í°­µµ ½ºÅ¸Æ¾ ´Üµ¶¿ä¹ý ´ëºñ ºñ¿­µîÇÏ´Ù´Â °á°ú°¡ LANCET¿¡ °ÔÀçµÆ´Ù. ¼¼ºê¶õ½ºº´¿ø È«¸í±â ±³¼öÆÀÀº º´¿ë¿ä¹ýÀÌ ´Üµ¶¿ä¹ýÀÇ ´ë¾ÈÀ¸·Î¼­...
Á¤¿¬ÁÖ ±âÀÚ  |  2024-01-15 16:28
¶óÀÎ
[Interview] ½ÉÇ÷°üÁúȯ ¿¹¹æ ÀÓ»ó±Ù°Å °í°­µµ ½ºÅ¸Æ¾ µ¶º¸Àû
Q. ´ç´¢º´¡¤ÀÌ»óÁöÁúÇ÷Áõ µ¿¹ÝÀÌȯ º´Å»ý¸®´Â?2Çü´ç´¢º´ ȯÀÚ¿¡¼­ µ¿¹ÝÀÌȯµÇ´Â ÀÌ»óÁöÁúÇ÷ÁõÀº °íLDLÄÝ·¹½ºÅ×·ÑÇ÷Áõ¡¤°íÁß¼ºÁö¹æÇ÷Áõ¡¤ÀúHDL...
ÀÌ»óµ· ±âÀÚ  |  2024-01-15 13:38
Back to Top